» Stayble Therapeutics shifts focus to phase Ib study in herniated disc
» Cline Scientific CEO convicted of market manipulation
» WntResearch CEO: “In a better position than ever”
» CLS looks forward to further expansion
» BrainCool on the agreements with the three largest purchasing organizations in the US
Read BioStock's weekly newsletter for v.46 here.
During October 25-26, BioStock Life Science Fall Summit at Medicon Village in Lund. See all the highlights from the event here!
Morning news
Sedana Medical obtains data exclusivity and market protection for Sedaconda (isoflurane) until 2031. Read more.
SyntheticMR has applied for 510(k) clearance for SyMRI 3D. Read more.
QuiaPEG provides further information about the transaction with Rosemonkey Ltd. Read more.
Redwood Pharma participates in the partner conference NLS Days in Copenhagen. Read more.
Medivir presenting at Redeye Life Science Day. Read more.
Texray completes a SEK 45 million investment round with Industrifonden. Read more.
AlzeCure presents at Stora Aktiedagarna in Stockholm on November 27. Read more.
Reports
News since Tuesday lunch
Peptonic Medical announced that the merger with Pharmiva is completed. Read more.
PolarCool signs individual agreements with the clubs in the SHL (Swedish Hockey League) for the current season. Read more.
Elos Medtechs largest owner EM Stakeholders invokes compulsory redemption proceedings. Read moreThe company is applying for delisting from Nasdaq Stockholm. Read more.
Orthoma has signed a Memorandum of Understanding with Johnson & Johnson KK. in Japan for knee surgery. Read more.
InDex Pharmaceuticals suspends the Phase III program with cobitolimod. Read more.
SensoDetect informed about the acquisition of EDOR. Read more.
Medim published an information memorandum regarding an upcoming rights issue. Read more.
Ultimovacs reported on insider trading. Read more.
OncoZenge announces that analyses of the new formulation of BupiZenge shows that it is clean. Read more.
Isofol Medical calls an extraordinary general meeting. Read more.
Bactiguard appoints patrick bach to new CFO. Read more.
Observe Medical provided updated information related to the rights issue. Read more.
Lipigon participating in Q&A at Redeye Life Science Day 2023. Read more.
BergenBio reported on insider trading. Read more.
This morning's price development
Winner: Hemcheck Sweden 34,53%, Asarina Pharma 15,83%, CHOSA Oncology 12,54%, Mendus 10,65%
Förlorare: Amniotics -60,5%, InDex Pharmaceuticals -59,38%, Raytelligence -16,67%, Inhalation Sciences -14,29%
Index: OMXS30 2208,69 0,52%, Healthcare 0,42%
More from BioStock
» Cereno's CEO pleased with secured financing
» Hectic days for Iconovo at BIO-Europe
» Lipum's SOL-116 attracted interest at BIO-Europe
» Respiratorius CEO: “Strong faith but patience regarding agreements”
» Elicera CEO: “iTANK has high potential in the treatment of solid tumors”